Elaxim 30 Injection
Marketer
Gennova Biopharmaceuticals Ltd
Salt Composition
Tenecteplase (30mg)
Overview Elaxim 30 Injection
Cardiolysin-30 Injection is a thrombolytic medication used in acute myocardial infarction treatment. It dissolves blood clots obstructing coronary arteries. Administered intravenously by a physician immediately upon suspected heart attack onset, careful monitoring of vital signs (including respiration, blood pressure, and oxygen saturation) is crucial. Concurrent or subsequent anticoagulant therapy may be employed. Hemorrhage is a prevalent adverse effect, potentially manifesting as injection site bleeding, epistaxis, hematuria, melena, or gastrointestinal bleeding. Caution is advised during activities involving sharp objects (e.g., shaving, nail trimming). Expert administration is mandatory; contraindications include recent head trauma or neurosurgery, and any active bleeding. Comprehensive medical history review is essential prior to its use.
Primary Ingredients of Elaxim 30 Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Elaxim 30 Injection
Myocardial infarction
Major Benefits of Elaxim 30 Injection:
The medication will be administered by your physician or their assistant; self-medication is strictly prohibited.
Common Side effects of Elaxim 30 Injection:
- Injection site bleeding
- Nosebleeds
- Blood in stool
- Blood in urine
- Gastrointestinal bleeding
How to use Elaxim 30 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Elaxim 30 Injection works:
Thrombolytic agent Elaxim 30 Injection breaks down dangerous blood clots within blood vessels. This action restores blood flow to compromised tissues, preventing further damage and improving patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Elaxim 30 Injection and alcohol is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Elaxim 30 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCAUTION
The administration of Elaxim 30 Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Irrelevant; Elaxim 30 Injection is administered solely to hospitalized individuals.
KidneyCONSULT YOUR DOCTOR
Data regarding Elaxim 30 Injection use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Elaxim 30 Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Elaxim 30 Injection :
NA
Facts to Know About Elaxim 30 Injection
| Label | Value |
|---|---|
| Chemical Category | Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Treatment Category | HEART |
| Action Class | Thrombolytic Agents (Plasminogen Activators) |
3,018 People bought this recently